Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chidamide”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07514936
What this trial is testing

Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid Leukaemia

Who this might be right for
Newly Diagnosed Acute Myeloid Leukemia (AML)Elderly Patients
Chinese PLA General Hospital 120
Testing effectiveness (Phase 2)Looking for participantsNCT05881265
What this trial is testing

Treatment of Chidamide and Venetoclax for Retinoic Acid and Arsenic Resistant Acute Promyelocytic Leukemia

Who this might be right for
APL
Shanghai Jiao Tong University School of Medicine 30
Testing effectiveness (Phase 2)UnknownNCT04724239
What this trial is testing

Sintilimab and Chidamide in Combination With or Without IBI305 in Advanced or Metastatic pMMR/MSS Colorectal Carcinoma

Who this might be right for
Advanced Microsatellite Stable Colorectal CancerMetastatic Microsatellite-stable Colorectal Cancer
Sun Yat-sen University 48
Testing effectiveness (Phase 2)UnknownNCT05367856
What this trial is testing

Efficacy and Safety of Chidamide Combined With BEAM Pretreatment Regimen in Autologous Transplantation for T-cell Lymphoma

Who this might be right for
T Cell Lymphoma
Ruijin Hospital 23
Large-scale testing (Phase 3)Looking for participantsNCT05768503
What this trial is testing

Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC

Who this might be right for
Metastatic Microsatellite-stable Colorectal Cancer
Sun Yat-sen University 176
Not applicableUnknownNCT05772728
What this trial is testing

Chidamide Combined With Azacitidine and Mitoxantrone Liposome in the Treatment of Relapsed/Refractory (nTFHL)

Who this might be right for
T Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 23
Testing effectiveness (Phase 2)UnknownNCT03410004
What this trial is testing

Chidamide for Patients With Relapse or Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Who this might be right for
Experimental
Chinese Academy of Medical Sciences 40
Testing effectiveness (Phase 2)UnknownNCT03611231
What this trial is testing

Chidamide Maintenance After Autologous Hematopoietic Stem Cell Transplantation for Relapsed, Refractory or High-risk Lymphoma

Who this might be right for
Experimental Tumor
Peking University 43
Testing effectiveness (Phase 2)UnknownNCT03151876
What this trial is testing

Chidamide Combined With Clad/Gem/Bu With AutoSCT in R/R Diffuse Large B Cell Lymphoma

Who this might be right for
Lymphoma
Sichuan University 93
Testing effectiveness (Phase 2)UnknownNCT03598959
What this trial is testing

Tofacitinib Combined With Chidamide in R/R ENKTCL

Who this might be right for
Extranodal NK/T-cell Lymphoma
Sichuan University 20
Testing effectiveness (Phase 2)Study completedNCT05632848
What this trial is testing

Chidamide Combined With Zimberelimab in the Treatment of Metastatic Triple-negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Sun Yat-sen University 47
Testing effectiveness (Phase 2)UnknownNCT04999540
What this trial is testing

Tucidinostat and Fulvestrant in Hormone-receptor Positive Advanced Breast Cancer

Who this might be right for
Breast Cancer
Guangdong Women and Children Hospital 73
Early research (Phase 1)Not Yet RecruitingNCT07635992
What this trial is testing

A Clinical Study Evaluating the Safety, Tolerability, and Effect on HIV Reservoir of Ibalizumab Combined With Chidamide (a Histone Deacetylase Inhibitor) in People Living With HIV

Who this might be right for
HIV (Human Immunodeficiency Virus)
First Affiliated Hospital of Zhejiang University 18
Testing effectiveness (Phase 2)UnknownNCT05495100
What this trial is testing

A Single-arm, Multicenter, Prospective Clinical Study of Mitoxantrone Liposome Combined With Chidamide and Azacitidine in the Treatment of Relapsed and Refractory Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 45
Large-scale testing (Phase 3)Looking for participantsNCT05931263
What this trial is testing

Clinical Trial Comparing Chi-BEAM With BEAM Regimen Combined With ASCT for the Treatment of ND PTCL

Who this might be right for
Newly Diagnosed Peripheral T-cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 104
Testing effectiveness (Phase 2)Looking for participantsNCT06637007
What this trial is testing

Phase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced Bone and Soft Tissue Sarcoma

Who this might be right for
Sarcoma,Soft TissueSarcomaSarcoma of Bone
Shanxi Province Cancer Hospital 30
Testing effectiveness (Phase 2)Study completedNCT04661943
What this trial is testing

Maintenance Therapy of Chidamide in Patients With HBV Positive Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Ou Bai, MD/PHD 30
Testing effectiveness (Phase 2)UnknownNCT04984018
What this trial is testing

Chidamide Plus Camrelizumab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 73
Testing effectiveness (Phase 2)UnknownNCT05390476
What this trial is testing

Tucidinostat and Metronomic Capecitabine for Metastatic Triple-negative Breast Cancer:a Multicenter,Open-label, Randomized Controlled, Phase II Clinical Trial

Who this might be right for
Triple Negative Breast Cancer
wang shusen 126
Testing effectiveness (Phase 2)UnknownNCT05747313
What this trial is testing

Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast Cancer

Who this might be right for
Breast CancerChemotherapy Effect
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Next Page